Company intelligence / Profile preview

Novagenetics

Ownership: Private
Development stage: Other

Overview

Novagenetics provides in-person medical genetic counseling and consulting services focused on hereditary risk assessment for cancer, metabolic disorders, neurodegenerative and cardiovascular diseases. The company also offers pharmacogenomic analysis to guide medication choices based on genetic makeup. Services include comprehensive family/personal history review by physicians with expertise in genetic medicine. No clinical trial results or therapeutic products reported.

Therapeutic areas: Metabolic DisordersNeurologyWomen's HealthOncologyCardiovascular
Modalities: Genetic testingPharmacogenomicsDiagnostic testingCarrier screening
Industry: Non-Academic Healthcare

Partnerships

No major pharmaceutical/biotech partnerships disclosed; works directly with patients and insurance providers as part of its service model

Beyond the preview

Go deeper on Novagenetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novagenetics.

Explore the full profile